Therapeutics Acquisition Corp.
Completed
Follow
Detailed Information
Information on this SPAC.
- IPO Size
- $100M
- Underwriters
- Focus
- Healthcare
- SEC Filings
- 1811764
- Public Embarc Page
- https://embarc.com/capital/spac/1811764/RACA/therapeutics-acquisition
- IPO Ticker
- RACA
SPAC Leadership
Information on the SPAC leadership.
- Chief Executive Officer and ChairmanPeter Kolchinsky, Ph.D.
- Chief Financial Officer and DirectorMatthew Hammond, Ph.D.
- DirectorDaniel S. Grau
- DirectorDavid C. Lubner
- DirectorMichael P. Gray
Target Information
Information on the SPAC target for merger.
- Company
- POINT Biopharma
- Presentation
- Investor Presentation (SEC) on 2021-03-15
- New Ticker
- PNT
- Description
- POINT Biopharma is "a late-stage biopharmaceutical company dedicated to bringing the many benefits of precision radiopharmaceutical therapies to patients with cancer."